Citation 160577

TANAKA,H: YOSHIOKA,T: SHIMAUCHI,Y: MATSUSHITA,Y: MATSUZAWA,Y: OKI,T: ISHIKURA,T:. (1982). CHEMICAL MODIFICATION OF ANTHRACYCLINE ANTIBIOTICS 4. SYNTHESIS OF NEW ANTHRACYLINES WITH TRISACCHARIDE.. 35()

Citation Details

Title	CHEMICAL MODIFICATION OF ANTHRACYCLINE ANTIBIOTICS 4. SYNTHESIS OF NEW ANTHRACYLINES WITH TRISACCHARIDE.
Authors	TANAKA,H: YOSHIOKA,T: SHIMAUCHI,Y: MATSUSHITA,Y: MATSUZAWA,Y: OKI,T: ISHIKURA,T:
Year	1982
Volume	35
Issue

Summary

Year: 1982

Journal: Unknown

Organisms and Their Experiments (13)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNORUBICIN	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNORUBICIN	ACTIVE
3	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAUNORUBICIN	WEAK ACTIVITY
4	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAUNORUBICIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ADRIAMYCIN	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ADRIAMYCIN	ACTIVE
3	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ADRIAMYCIN	EQUIVOCAL
4	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ADRIAMYCIN	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARMINOMYCIN I	ACTIVE
2	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	CARMINOMYCIN I	WEAK ACTIVITY
3	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	CARMINOMYCIN I	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ACLACINOMYCIN A	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ACLACINOMYCIN A	ACTIVE
3	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ACLACINOMYCIN A	WEAK ACTIVITY
4	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ACLACINOMYCIN A	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORFIELD DESORPTION MASS SPECTRUM OF	DAUNOMYCINONE,3''-O-ACETYL: TRISACCHARIDE	None
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,3''-O-ACETYL: TRISACCHARIDE	ACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,3''-O-ACETYL: TRISACCHARIDE	ACTIVE
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,3''-O-ACETYL: TRISACCHARIDE	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,3''-O-ACETYL: TRISACCHARIDE	ACTIVE
6	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAUNOMYCINONE,3''-O-ACETYL: TRISACCHARIDE	WEAK ACTIVITY
7	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAUNOMYCINONE,3''-O-ACETYL: TRISACCHARIDE	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORFIELD DESORPTION MASS SPECTRUM OF	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	None
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	INACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
6	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	WEAK ACTIVITY
7	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORFIELD DESORPTION MASS SPECTRUM OF	DAUNOMYCINONE,7-O-(O-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	None
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	INACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	INACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
7	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAUNOMYCINONE,7-O-(O-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	WEAK ACTIVITY
8	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAUNOMYCINONE,7-O-(O-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORFIELD DESORPTION MASS SPECTRUM OF	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-(N-METHYL-ALPHA-L-DAUNOSAMINYL):	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-(N-METHYL-ALPHA-L-DAUNOSAMINYL):	ACTIVE
3	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-(N-METHYL-ALPHA-L-DAUNOSAMINYL):	WEAK ACTIVITY
4	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-(N-METHYL-ALPHA-L-DAUNOSAMINYL):	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTEDFIELD DESORPTION MASS SPECTRUM OF	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-DAUNOSAMINYL):	None
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-DAUNOSAMINYL):	ACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-DAUNOSAMINYL):	ACTIVE
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-DAUNOSAMINYL):	ACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-DAUNOSAMINYL):	INACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-DAUNOSAMINYL):	ACTIVE
7	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-DAUNOSAMINYL):	EQUIVOCAL
8	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DAUNOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-DAUNOSAMINYL):	ACTIVE
9	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL)-14-O-ACETYL:	None
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL)-14-O-ACETYL:	ACTIVE
11	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL)-14-O-ACETYL:	WEAK ACTIVITY
12	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL)-14-O-ACETYL:	None

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL)-14-O-PHENYL-ACETYL:	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL)-14-O-PHENYL-ACETYL:	ACTIVE
3	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL)-14-O-PHENYL-ACETYL:	EQUIVOCAL
4	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL)-14-O-PHENYL-ACETYL:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORFIELD DESORPTION MASS SPECTRUM OF	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	None
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	INACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
7	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	WEAK ACTIVITY
8	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
3	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	WEAK ACTIVITY
4	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ADRIAMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	CARMINOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	None
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARMINOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARMINOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARMINOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARMINOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARMINOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE
7	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	CARMINOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	WEAK ACTIVITY
8	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	CARMINOMYCINONE,7-O-(O-ALPHA-L-CINERULOSYL-(1-4)-O-(3-O-ACETYL-2-DEOXY-ALPHA-L-FUCOSYL)-(1-4)-ALPHA-L-RHODOSAMINYL):	ACTIVE

Show SPARQL Queries (1)